Omidubicel-Onlv: The First Commercially Available Alternative Allogeneic Hematopoietic Stem Cell Transplantation Donor Source
Omidubicel provides an alternative donor source for patients undergoing alloHSCT for whom there is no matched donor available. This need may be particularly great in ethnic and racial minority populations who may be underrepresented in the NMDP BioTherapies database.
Authors
- Martha Lassiter
- Charlotte Lail
Institutions
- Charlotte School of Law (US)
- St.Martha's College Of Nursing (IN)
Publication Details
- Journal
- Clinical journal of oncology nursing
- Published
- 2025-05-22
- DOI
- https://doi.org/10.1188/25.cjon.230-236
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00